Team Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
Team Financial Group's XPH Position: Q3 2026 in Review
Team Financial Group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 1,000 shares worth $65K. The stake represents 0.03% of the portfolio and ranks #107 among its holdings. This is a return to the name: Team Financial Group previously reported a position in XPH as recently as Q1 2026.
Team Financial Group first reported a position in XPH in Q4 2025 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold XPH as of Q3 2026.
- Team Financial Group held 1,000 shares of State Street SPDR S&P Pharmaceuticals ETF worth $65K as of Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF was a new Team Financial Group position in Q3 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up 0.03% of Team Financial Group's portfolio in Q3 2026, its #107 holding.
- Team Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
- 107 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.
Based on Team Financial Group's 13F filing for Q3 2026, filed 30 Oct 2026.